A hospitalized patient triggers a major setback for Intellia's $1.9B flagship drug, shaking investor faith overnight ...

In a first for adults in Singapore, scientists are conducting gene editing trials on heart patients to correct defects at ...

Over the past two decades, synthetic biology has fueled advancements across a broad range of disciplines, including agriculture, bioremediation, biofuel production, and chemical manufacturing. Today, ...

The goal of gene therapy is to permanently cure hereditary diseases. One of the most promising technologies for this is the ...

The news for the chocolate industry is a welcome development, as businesses and scientists grapple with crop shortages.

Chocolate prices have been rising due to complications in the supply chain, but Penn State researchers have made a ...

Most current approaches rely on adding nuclear localization signal (NLS) motifs to the ends of Cas9 to facilitate nuclear entry. However, this method is inefficient, and much of the Cas9 that is ...

Intellia Therapeutics, Inc. is rated Hold due to uncertainty from dosing pause in its MAGNITUDE program for ATTR. Learn more ...

The invention has made it onto TIME’s 2025 Best Inventions list, in the food and drink category, and would be the first new ...

A researcher at the University of Houston finds management of diabetic ketoacidosis may center around reducing ketone levels ...